MedTrace Logo

Caroverin and Inner Ear Diseases

NCT01174979 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2015-08-07

No results posted yet for this study

Summary

This trial is a randomized, double blind, placebo controlled study on patients suffering from inner ear diseases with tinnitus as a principal symptom.

The study will investigate the transtympanic treatment with a 1,5 % caroverine solution.

Each patient will undergo treatment for 2 cycles of 48 hours each.

Conditions

  • Tinnitus

Interventions

DRUG

Caroverin

treatment with eardrops 2 times for 48 hours

Sponsors & Collaborators

  • Phafag AG

    lead INDUSTRY

Principal Investigators

  • Wolfgang Elsaesser, Dr. · Landeskrankenhaus Feldkirch

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2015-08-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01174979 on ClinicalTrials.gov